Sandip Kapadia Insider Trading
Get free email notifications about insider trading for Sandip Kapadia.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Sandip Kapadia. Sandip Kapadia is a CFO and Treasurer in INTERCEPT PHARMACEUTICALS, INC. ($ICPT) and a Chief Financial Officer in INTERCEPT PHARMACEUTICALS INC ($ICPT) and a Director in Passage BIO, Inc. ($PASG) and a Chief Financial Officer in Harmony Biosciences Holdings, Inc. ($HRMY).
Address: C/O INTERCEPT PHARMACEUTICALS, INC. 450 W. 15TH STREET, SUITE 505 NEW YORK 10011 NY
Companies in which Sandip Kapadia is an Insider
Harmony Biosciences Holdings, Inc.
Trading Symbol: HRMYIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Sandip Kapadia: Chief Financial Officer
Holdings: 0 shares
Latest Transaction: Mar 31 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
INTERCEPT PHARMACEUTICALS, INC.
Trading Symbol: ICPTIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Sandip Kapadia: CFO and Treasurer, Chief Financial Officer
Holdings: 40,964 shares
Current Value: $4,652,281
Latest Transaction: Jan 26 2021
$ICPT Market Capitalization: $2.80B
$ICPT Previous Close: $113.57
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Passage BIO, Inc.
Trading Symbol: PASGIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Sandip Kapadia: Director
Holdings: 0 shares
Latest Transaction: May 28 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Sandip Kapadia
Sentiment: All, HRMY, ICPT, PASG
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 28 2021 | PASG | Passage BIO, Inc. | Kapadia Sandip | Director | Option Exercise | A | 13.83 | 16,918 | 233,976 | 16,918 | |
Mar 31 2021 | HRMY | Harmony Bioscience ... | Kapadia Sandip | Chief Financial Off ... | Option Exercise | A | 29.03 | 230,000 | 6,676,900 | 230,000 | |
Mar 31 2021 | HRMY | Harmony Bioscience ... | Kapadia Sandip | Chief Financial Off ... | Option Exercise | A | 0.00 | 60,000 | 0 | 60,000 | |
Jan 26 2021 | ICPT | INTERCEPT PHARMACE ... | Kapadia Sandip | CFO and Treasurer | Option Exercise | A | 29.46 | 26,900 | 792,474 | 26,900 | |
Jan 26 2021 | ICPT | INTERCEPT PHARMACE ... | Kapadia Sandip | CFO and Treasurer | Grant | A | 0.00 | 17,200 | 0 | 40,964 | 23.8 K to 41 K (+72.38 %) |
Dec 16 2020 | ICPT | INTERCEPT PHARMACE ... | Kapadia Sandip | CFO and Treasurer | Sell | S | 32.78 | 1,763 | 57,791 | 27,158 | 28.9 K to 27.2 K (-6.10 %) |
Jul 06 2020 | ICPT | INTERCEPT PHARMACE ... | Kapadia Sandip | CFO and Treasurer | Payment of Exercise | F | 46.52 | 615 | 28,610 | 29,217 | 29.8 K to 29.2 K (-2.06 %) |